Abstract
Nanoparticles prepared from natural or synthetic polymers have shown potential for antigen and DNA vaccine delivery to mucosal surfaces. The purpose of this research was to prepare chitosan/poly-e-caprolactone (Chitosan/ PCL) nanoparticles and PCL nanoparticles and evaluate their potential as DNA and protein/vaccine delivery systems. Both preparation methods resulted in particles of low cytotoxicity and sizes suggested to be ideal to be taken up by cells (199 ± 62 nm and 165 ± 35 nm, respectively for chitosan/PCL and PCL nanoparticles). However, Chitosan/ PCL nanoparticles offered considerable advantages over PCL nanoparticles as antigen and DNA delivery system. Namely, higher loading efficacies for model antigens studied (myoglobin, BSA, ovalbumin, lactalbumin, α-casein and lysozyme), much higher uptake by A549 cells, great ability to form stable complexes, which protect DNA from nucleases. However, in spite of good DNA and protein loading capabilities, Chitosan/PCL nanoparticles showed much better qualities as a protein delivery system since the rate of cells transfected were not very high.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
